Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in Children
NCT00458588 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 301
Last updated 2017-04-06
Summary
RATIONALE: The amount and type of fat in the diet may affect hormone levels, bone mineral density, and breast density later in life. This may affect the risk of developing breast cancer. Learning about the long-term effects of diet on hormone levels, bone mineral density, and breast density may help the study of breast cancer in the future.
PURPOSE: This clinical trial is studying the long-term effect of adolescent diet on hormones and breast cancer risk in women previously enrolled in the Dietary Intervention Study in Children.
Conditions
Interventions
- OTHER
-
physiologic testing
- OTHER
-
questionnaire administration
- PROCEDURE
-
breast imaging study
- PROCEDURE
-
dual x-ray absorptometry
- PROCEDURE
-
evaluation of cancer risk factors
- PROCEDURE
-
magnetic resonance imaging
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Fox Chase Cancer Center
lead OTHER
Principal Investigators
-
Joanne Dorgan, PhD, MPH · Fox Chase Cancer Center
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-09-30
- Primary Completion
- 2013-10-31
- Completion
- 2013-10-31
Countries
- United States
Study Locations
More Related Trials
-
Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
NCT00005886 ·Status: COMPLETED ·Phase: PHASE1
-
Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
NCT00005079 ·Status: COMPLETED ·Phase: PHASE3
-
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer
NCT02598557 ·Status: COMPLETED ·Phase: PHASE2
-
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
NCT05941520 ·Status: RECRUITING ·Phase: PHASE2
-
Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg
NCT00859560 ·Status: COMPLETED
-
Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer
NCT00691509 ·Status: UNKNOWN
-
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer
NCT00569543 ·Status: COMPLETED
-
Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast
NCT00943527 ·Status: COMPLETED
-
Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer
NCT00086749 ·Status: COMPLETED
-
Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer
NCT00066586 ·Status: COMPLETED ·Phase: NA
-
Radiologic Evaluation and Breast Density (READ)
NCT00117663 ·Status: COMPLETED ·Phase: NA
-
The Role of Diet and Lifestyle in Breast Cancer Survival
NCT00701584 ·Status: UNKNOWN
-
Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer
NCT01298362 ·Status: COMPLETED
-
Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer
NCT00005605 ·Status: COMPLETED
-
Testosterone Implants and the Incidence of Breast Cancer
NCT03768258 ·Status: COMPLETED
-
Examining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated Patients
NCT01983995 ·Status: COMPLETED
-
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
NCT00080756 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Individuals on Hormone Therapy Breast Cancer Screening Pilot
NCT06383026 ·Status: RECRUITING
-
Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen
NCT00764322 ·Status: COMPLETED ·Phase: PHASE2
-
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
NCT01219075 ·Status: COMPLETED ·Phase: NA
-
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
NCT00002582 ·Status: COMPLETED ·Phase: PHASE3
-
Chronic Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer
NCT06776458 ·Status: RECRUITING
-
Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer
NCT00253539 ·Status: COMPLETED ·Phase: PHASE2
-
Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer
NCT06781762 ·Status: RECRUITING
-
A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer
NCT04298086 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2